Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 530991000036117 | poractant alfa 240 mg/3 mL intratracheal suspension, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 531001000036118 | poractant alfa 240 mg / 3 mL intratracheal suspension, 3 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | Is a | poractant alfa | true | Inferred relationship | Some | ||
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | has intended active ingredient | poractant alfa | true | Inferred relationship | Some | 1667934268 | |
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | has Australian BoSS | poractant alfa | true | Inferred relationship | Some | 1667934268 | |
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | has manufactured dose form | intratracheal suspension | true | Inferred relationship | Some | ||
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | has unit of use | vial | true | Inferred relationship | Some | 1667934269 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Curosurf 240 mg/3 mL intratracheal suspension, 3 mL vial | Is a | True | poractant alfa 240 mg/3 mL intratracheal suspension, vial | Inferred relationship | Some | |
| poractant alfa 240 mg/3 mL intratracheal suspension, 3 mL vial | has MPUU | True | poractant alfa 240 mg/3 mL intratracheal suspension, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR